A Study of ES104 in Patients With Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
A Screening Study Targeting Tumor-specific Antigens
- Status
- COMPLETED
- Phase
- N/A
A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pressure-enabled Delivery in Radioembolization (TriNav Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRC
- Status
- UNKNOWN
- Phase
- PHASE2
Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece
- Status
- COMPLETED
- Phase
- N/A
Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC
- Status
- TERMINATED
- Phase
- PHASE2
The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- NA